Navigation Links
Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity
Date:9/6/2011

#8211;2010 46

Figure 29: Licensing Strategies in Large Pharmaceutical Companies, Abbott, Licensing Deals By Type, 2009 – Q1 2011 47

Figure 30: Licensing Strategies in Large Pharmaceutical Companies, Abbott, Licensing Deals By Geography 2009 – Q1 2011 48

Figure 31: Licensing Strategies in Large Pharmaceutical Companies, Abbott, Licensing Deals By Therapy Area, 2009 – Q1 2011 49

Figure 32: Licensing Strategies in Large Pharmaceutical Companies, Abbott, Licensing Deals By Phase, 2009 – Q1 2011 50

Figure 33: Licensing Strategies in Large Pharmaceutical Companies, Eli Lilly, Number of Licensing Deals, 2005 – Q1 2011 51

Figure 34: Licensing Strategies in Large Pharmaceutical Companies, Eli Lilly, Licensing Deals By Value, 2006–2010 52

Figure 35: Licensing Strategies in Large Pharmaceutical Companies, Eli Lilly, Number of Licensing Deals, By Value, 2005 – Q1 2011 53

Figure 36: Licensing Strategies in Large Pharmaceutical Companies, Eli Lilly, Licensing Deals By Type, 2009 – Q1 2011 54

Figure 37: Licensing Strategies in Large Pharmaceutical Companies, Eli Lilly, Licensing Deals By Geography, 2009 – Q1 2011 55

Figure 38: Licensing Strategies in Large Pharmaceutical Companies, Eli Lilly, Licensing Deals By Therapy Area, 2009 – Q1 2011 56

Figure 39: Licensing Strategies in Large Pharmaceutical Companies, Eli Lilly, Licensing Deals By Phase, 2009 – Q1 2011 57

Figure 40: Licensing Strategies in Large Pharmaceutical Companies, Novartis, Number of Licensing Deals, 2005 – Q1 2011 58

Figure 41: Licensing Strategies in Large Pharmaceutical Companies, Novartis, Licensing Deals By Value, 2006–2010 59

Figure 42: Licensing Strategies in Large Pharmaceutical Companies, Novartis, Number of Licensing Deals By Value, 2005 – Q1 2011 60

Figure 43: Licensing Strategies in Large Pharmaceutical Companies, Novar
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
2. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
3. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
4. Lilly and TransPharma Medical Announce Licensing and Development Agreement
5. Genzyme and Isis Complete Licensing of Mipomersen
6. MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
7. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
8. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
9. Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays
10. Ironwood Announces Linaclotide European Licensing Agreement with Almirall
11. Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014 The ... physicians is spreading to previously rep-friendly specialties, according ... sales and marketing consulting firm ZS Associates.      ... than 200 U.S. pharmaceutical sales teams. The report ... prescribers meet with the pharmaceutical sales reps who ...
(Date:7/22/2014)... July 22, 2014  Pressure BioSciences, Inc. ... Parabase Genomics ("Parabase"), (together "the companies"), today ... research and development agreement (the "collaboration"). Under ... develop a front-end, sample preparation method for ... confirmatory testing process. The sample preparation method ...
(Date:7/22/2014)... 2014 Glide ... on solid dose formulations of therapeutics and vaccines, ... octreotide acetate achieved successful results in a pre-clinical ... liquid product (Sandostatin®).  Based on these results, the ... to a contract manufacturing organisation (CMO), and to ...
Breaking Medicine Technology:Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 3Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 4Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 5Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform 2Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform 3Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform 4Glide Pharma Completes Successful Proof-of-Concept Study with Novel Solid Dose Formulation of Octreotide 2
... Corp. (NYSE: CFN ), a leading, global medical ... Sept. 30, 2010. "Our adjusted EPS results for ... highlighted a strong quarter for our Infusion, Dispensing, Infection Prevention ... of CareFusion. "In the first quarter we essentially overcame $60 ...
... 2, 2010 Elekta,s MOSAIQ® Oncology PACS has evolved ... image and data management solution for oncology professionals that ... information and address the requirements of the modern oncology ... System (OIS), MOSAIQ Data Director transforms the patient ...
Cached Medicine Technology:CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 2CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 3CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 4CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 5CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 6CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 7CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 8CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 9CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance 10Elekta Introduces MOSAIQ Data Director, Image and Data Hub for Oncology 2Elekta Introduces MOSAIQ Data Director, Image and Data Hub for Oncology 3Elekta Introduces MOSAIQ Data Director, Image and Data Hub for Oncology 4
(Date:7/22/2014)... 2014 The market for botulinum neurotoxin ... years, owing to novel medical indications created and due ... aging societies where physical appearance is extremely valued. Although ... current competitors, new companies and technologies are setting ground ... will put the price of 1st-gen products under pressure, ...
(Date:7/22/2014)... HealthDay Reporter TUESDAY, July ... minimally invasive procedure known as morcellation carries a risk of ... likelihood more clearly. Twenty-seven of every 10,000 women who ... of the procedure, researchers found, with the odds being highest ... a hysterectomy with morcellation use a power cutter to slice ...
(Date:7/22/2014)... Montreal, July 22, ... for a cigarette twice as often as smokers who are ... the hardest time shaking off the habit may have more ... Those insights were among the collective findings recently published in ... team of researchers based in part at Concordia University. , ...
(Date:7/22/2014)... 5i Sciences, a medical technology company focused ... Coye, M.D., M.P.H. to a role as Senior Consultant. ... the market introduction of innovative technologies that impact healthcare ... on strategies for building a successful commercial healthcare enterprise ... Coye is currently the Chief Innovation Officer of UCLA ...
(Date:7/22/2014)... Latin America Drilling fluid and Completion fluid Market Report defines ... Latin America with analysis and forecast of revenue. The drilling ... to grow from around $0.93 billion in 2013 to $1.45 ... given period. , Browse through the TOC of the Latin ... an idea of the in-depth analysis provided. This also provides ...
Breaking Medicine News(10 mins):Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 3Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 4Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 2Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 3Health News:Extra exercise helps depressed smokers kick the habit faster 2Health News:5i Sciences Announces Appointment of a Senior Healthcare Consultant and Successful Financing 2Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 5Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 6
... ... for Employees, SACRAMENTO, Calif., Sept. 8 Kurt Wetzel lost ... is seeing decreased absenteeism and lower levels of stress and,burnout among ... a,partner. And a recent study shows that employers are seeing initial ...
... WASHINGTON, Sept. 8 Parents probably,wouldn,t have guessed, ... finds middle-school students enjoy soyfoods as much as ... enjoy with tasty,and nutritious soyfoods., A plate ... took popular,menu items, including macaroni & cheese, burgers, ...
... One million Swiss Francs (around $ 885 thousand, 400 ... the amount must be destined by the winners to research ... the 2008 Balzan Prize winners were announced today in a ... Roma "La Sapienza", for the Visual Arts since 1700, Thomas ...
... patients using proton pump inhibitor (PPI) drugs. The drugs are used ... as other stomach/intestinal issues including ulcers, gastroesophageal reflux disease (GERD), dyspepsia, ... ... Denver, CO (PRWEB) September 8, 2008 -- LegalView, the number ...
... half of older patients successfully treated for colorectal cancer ... of cancer. The study, appearing in the October 15, ... of the American Cancer Society, indicates poor compliance to ... , Patients who undergo potentially curative surgery for colorectal ...
... Leaders to, Join the Smokefree Air 2010 Challenge and ... 8 College students are,falling victim to aggressive tobacco ... according to a new report released today by the,American ... of the current status of,tobacco use and policies on ...
Cached Medicine News:Health News:'Live Well for Life' Benefits Companies and Workers 2Health News:'Live Well for Life' Benefits Companies and Workers 3Health News:'Live Well for Life' Benefits Companies and Workers 4Health News:Back to School With Soy 2Health News:Balzan Foundation announced 2008 prize winners 2Health News:Balzan Foundation announced 2008 prize winners 3Health News:LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug 2Health News:LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug 3Health News:LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug 4Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Big Tobacco's Grip on Colleges and Students Loosens, But Still Holding Strong: New Report Examines Trends on Campuses 2Health News:Big Tobacco's Grip on Colleges and Students Loosens, But Still Holding Strong: New Report Examines Trends on Campuses 3Health News:Big Tobacco's Grip on Colleges and Students Loosens, But Still Holding Strong: New Report Examines Trends on Campuses 4
Double-ended. 5 mm x 7 mm tips. Designated most popular model or size....
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
Double-ended. 6 mm x 9 mm and 6 mm x 11 mm tips....
Designated most popular model or size. 3 mm tip....
Medicine Products: